(July 14, 2017, 1:31 PM EDT) -- BOSTON — A federal judge should grant a motion for class certification filed by lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive officers because the lead plaintiffs have satisfied all statutory requirements for certification, the lead plaintiffs argue in a motion for class certification filed June 29 in Massachusetts federal court (In re AVEO Pharmaceuticals Inc. Securities Litigation, No. 13-11157, D. Mass.)....